Gempaz 10mg Tablet
₨ 325
About this product
Overview
Gempaz 10mg Tablet contains the active ingredient Empagliflozin. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Empagliflozin works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels in individuals with type 2 diabetes mellitus.
Uses
- Type 2 diabetes mellitus: Gempaz 10mg Tablet is prescribed for the management of type 2 diabetes mellitus in adults. It helps improve glycemic control by reducing blood glucose levels through increased urinary glucose excretion.
- Blood sugar control: Empagliflozin helps lower fasting and postprandial blood sugar levels, thereby reducing the risk of hyperglycemia and diabetes-related complications.
- Cardiovascular protection: Empagliflozin has been shown to provide cardiovascular benefits by reducing the risk of cardiovascular events, such as heart attack, stroke, and cardiovascular death, in patients with type 2 diabetes mellitus and established cardiovascular disease.
Side Effects
- Common side effects of Gempaz 10mg Tablet may include:
- Genital yeast infections
- Urinary tract infections
- Increased urination
- Thirst
- Dizziness
- Hypotension (low blood pressure)
- Serious but rare side effects may include ketoacidosis (high levels of ketones in the blood), hypoglycemia (low blood sugar), or allergic reactions. Contact your healthcare provider if you experience any severe or persistent side effects.
Precautions
- Take Gempaz 10mg Tablet exactly as prescribed by your healthcare provider.
- Inform your doctor about any pre-existing medical conditions, especially kidney or liver disease, heart failure, or a history of diabetic ketoacidosis, before starting Empagliflozin therapy.
- Monitor your blood sugar levels regularly while taking Gempaz Tablet, and report any significant changes or episodes of hypoglycemia to your healthcare provider.
- Stay well-hydrated and maintain adequate fluid intake while on Empagliflozin therapy to reduce the risk of dehydration and related complications.
When Not to Use
Avoid using Gempaz 10mg Tablet if:
- You have a known allergy to Empagliflozin or any other ingredients in the tablet.
- You have severe kidney impairment (eGFR less than 30 mL/min/1.73 m²) or end-stage renal disease (ESRD), as Empagliflozin may not be recommended in these patients.
- You are pregnant, planning to become pregnant, or breastfeeding without consulting your healthcare provider.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Substitutes for Gempaz 10mg Tablet
These medicines contain the same salt as Gempaz 10mg Tablet (Empagliflozin 10mg), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Voreta 10mg Tablet | Scotman Pharmaceuticals | 10 tablets | Rs 240 |
| Jemvesta 10mg Tablet | Wilshire Laboratories | 14 tablets | Rs 280 |
| Emglif 10mg Tablet | Genix Pharma | 14 tablets | Rs 285 |
| Boschempa 10mg Tablet | Bosch Pharmaceuticals | 14 tablets | Rs 300 |
| Diajard 10mg Tablet | Highnoon Laboratories | 14 tablets | Rs 308 |
| Truglif 10mg Tablet | ALI Gohar Pharmaceuticals | 14 tablets | Rs 310 |
| Glempa 10mg Tablet | Nabiqasim Industries | 14 tablets | Rs 345.88 |
| Glempa 10mg Tablets 14s | Nabiqasim Industries | 14 tablets | Rs 346 |
Other strengths of Empagliflozin
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Voreta 25mg Tablet | Scotman Pharmaceuticals | 25mg | Rs 340 |
| Boschempa 25mg Tablet | Bosch | 25mg | Rs 450 |
| Truglif 25mg Tablet | ALI Gohar Pharmaceuticals | 25mg | Rs 460 |
| Gempaz 25mg Tablet | LCI Pharmaceuticals | 25mg | Rs 470.59 |
See all brands and prices on our Empagliflozin page.
Customer reviews
You must be logged in to post a review.




Reviews
Clear filtersThere are no reviews yet.